Aspiriant LLC’s American International AIG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$274K Buy
+3,682
New +$285K 0.01% 339
2026
Q2
– Sell
-2,953
Closed -$222K – 403
2026
Q1
$222K Sell
2,953
-102
-3% -$7.8K 0.01% 321
2025
Q4
$261K Sell
3,055
-67
-2% -$5.36K 0.01% 289
2025
Q3
$245K Sell
3,122
-383
-11% -$30.6K 0.01% 273
2025
Q2
$300K Buy
3,505
+2
+0.1% +$167 0.01% 253
2025
Q1
$305K Buy
3,503
+580
+20% +$45.1K 0.01% 236
2024
Q4
$213K Buy
2,923
+2
+0.1% +$150 0.01% 277
2024
Q3
$214K Buy
2,921
+5
+0.2% +$373 0.01% 276
2024
Q2
$216K Sell
2,916
-1,929
-40% -$147K 0.01% 267
2024
Q1
$379K Sell
4,845
-572
-11% -$40.8K 0.02% 225
2023
Q4
$367K Buy
5,417
+178
+3% +$11.3K 0.02% 221
2023
Q3
$317K Buy
5,239
+261
+5% +$15.6K 0.02% 215
2023
Q2
$286K Buy
+4,978
New +$267K 0.01% 231
2023
Q1
– Sell
-3,203
Closed -$203K – 277
2022
Q4
$203K Buy
+3,203
New +$186K 0.01% 266

Other funds holding AIG

Aspiriant LLC's AIG Position: Q3 2026 in Review

Aspiriant LLC opened a new position in American International (AIG) in Q3 2026: 3,682 shares worth $274K. The stake represents 0.01% of the portfolio and ranks #339 among its holdings. This is a return to the name: Aspiriant LLC previously reported a position in AIG as recently as Q1 2026.

Aspiriant LLC first reported a position in AIG in Q4 2022 and has held it in 14 quarters since. The position peaked at $379K in Q1 2024. 698 funds tracked by Wall St. Rank hold AIG as of Q3 2026.

  • Aspiriant LLC held 3,682 shares of American International worth $274K as of Q3 2026.
  • American International was a new Aspiriant LLC position in Q3 2026.
  • American International made up 0.01% of Aspiriant LLC's portfolio in Q3 2026, its #339 holding.
  • Aspiriant LLC first reported a position in American International in Q4 2022 and has held it in 14 quarters since.
  • Aspiriant LLC's American International position peaked at $379K in Q1 2024.
  • 698 funds tracked by Wall St. Rank held American International as of Q3 2026.

Based on Aspiriant LLC's 13F filing for Q3 2026, filed 16 Oct 2026.